In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 10.63 above Mobia Medical Inc average.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Quick Ratio than Mobia Medical Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 0 to 330.

Explain Quick Ratio?
How much Cash & cash equivalents MOBI�s has?
What are MOBI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MOBI Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q3	Q2
Y / Y Current Liabilities Change	-	-	-	-	-
Y / Y Cash & cash equivalent Change	-	-	-	-	-
Quick Ratio MRQ	10.63	18.69	5.72	3.29	-
MOBI's Total Ranking	# 330	# 0	#	#	#
Seq. Current Liabilities Change	59.53 %	-2.82 %	-4.47 %	-	-
Seq. Cash & cash equivalent Change	-9.26 %	217.79 %	65.91 %	-	-

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 8
Healthcare Sector	# 130
Overall Market	# 330

Quick Ratio Statistics
High	Average	Low
12.24	6.75	3.29
(Jun 30 2026)		(Dec 31 2025)

Financial Statements
Mobia Medical Inc 's Current Liabilities	$ 15 Millions	Visit MOBI's Balance sheet
Mobia Medical Inc 's Cash & cash equivalent	$ 161 Millions	Visit MOBI's Balance sheet
Source of MOBI's Sales		Visit MOBI's Sales by Geography

Cumulative Mobia Medical Inc 's Quick Ratio

MOBI's Quick Ratio for the trailling 12 Months

MOBI Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	12 Months
Y / Y Current Liabilities TTM Growth	-	-	-	-	-
Y / Y Cash & cash equivalent TTM Growth	-	-	-	-	-
Quick Ratio TTM	9.59	9.05	4.48	3.29	-
Total Ranking TTM	#	#	#	#
Seq. Current Liabilities TTM Growth	51.36 %	47.48 %	95.53 %	-	-
Seq. Cash & cash equivalent TTM Growth	60.32 %	198.28 %	165.91 %	-	-

Quick ratio ranking by company, industry and sector >> Back to MOBI Financial Strength Comparisons >> Go to Compare MOBI Quick Ratio to its Competitors

On the trailing twelve months basis MOBI Cash & cash equivalent decreased by -9.26 % in Q3 2026 year on year, faster than Current Liabilities, this led to increase in in Mobia Medical Inc 's Quick Ratio to 9.59, above MOBI average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 7 other companies have achieved higher Quick Ratio than Mobia Medical Inc . While overall ranking is unchanged compared to the previous 12 months at no. 0.

Explain Quick Ratio?
How much Cash & cash equivalents MOBI�s has?
What are MOBI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 8
Healthcare Sector	# 130
Within the Market	# 330

trailing twelve months Quick Ratio Statistics
High	Average	Low
12.24	6.75	3.29
(Jun 30 2026)		(Dec 31 2025)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Bone Biologics Corporation	12.66	$ 6.088 Millions	$ 0.481 Millions
Lemaitre Vascular Inc	11.26	$ 389.721 Millions	$ 34.620 Millions
Mobia Medical Inc	10.63	$ 160.692 Millions	$ 15.115 Millions
Axogen inc	9.55	$ 348.068 Millions	$ 36.456 Millions
Envveno Medical Corporation	7.13	$ 18.472 Millions	$ 2.589 Millions
Ceribell Inc	6.51	$ 117.467 Millions	$ 18.034 Millions
Iradimed Corporation	6.13	$ 63.288 Millions	$ 10.323 Millions
Clearpoint Neuro Inc	4.68	$ 46.184 Millions	$ 9.869 Millions
Cvrx inc	4.67	$ 58.746 Millions	$ 12.583 Millions
Dexcom Inc	4.25	$ 964.800 Millions	$ 227.000 Millions
Sight Sciences Inc	3.84	$ 77.402 Millions	$ 20.137 Millions
Profound Medical Corp	3.41	$ 33.343 Millions	$ 9.771 Millions
Rxsight Inc	3.40	$ 254.683 Millions	$ 74.952 Millions
Omada Health Inc	3.23	$ 243.151 Millions	$ 75.379 Millions
Transmedics Group Inc	3.22	$ 492.962 Millions	$ 152.857 Millions
Procept Biorobotics Corporation	3.10	$ 218.369 Millions	$ 70.353 Millions
Outset Medical Inc	3.07	$ 136.627 Millions	$ 44.453 Millions
Sharps Technology Inc	2.82	$ 7.478 Millions	$ 2.650 Millions
Edwards Lifesciences Corporation	2.81	$ 4,683.700 Millions	$ 1,664.300 Millions
Mimedx Group Inc	2.81	$ 120.791 Millions	$ 43.031 Millions
Pulse Biosciences Inc	2.74	$ 36.725 Millions	$ 13.395 Millions
Staar Surgical Co	2.73	$ 206.414 Millions	$ 75.541 Millions
Medinotec Inc	2.68	$ 2.584 Millions	$ 0.963 Millions
Glaukos Corp	2.66	$ 337.478 Millions	$ 126.726 Millions
Pulmonx Corporation	2.57	$ 53.245 Millions	$ 20.739 Millions
Beta Bionics Inc	2.48	$ 81.551 Millions	$ 32.836 Millions
Irhythm Holdings Inc	2.46	$ 560.719 Millions	$ 228.025 Millions
Apyx Medical Corp	2.37	$ 25.777 Millions	$ 10.870 Millions
Atricure Inc	2.23	$ 187.031 Millions	$ 83.972 Millions

Date modified: 2026-11-06T12:59:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.